Additionally, treatment of both cell lines with CM obtained from ADAMTS1-overexpressing cells also induced EGFR activation, while CM from RCC cells with ADAMTS1 overexpression and VCAN-KD failed to trigger EGFR activation (Additional file 1: Supplementary Fig. 5F). This evidence concerns the gene ADAMTS1 and renal cell carcinoma.